🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(31)
All (303)
Buys (31)
Sells (272)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Annovis Bio, Inc.
(ANVS)
Hoffman Michael B
— Director
Apr 2, 2026
Purchase
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Lipocine Inc.
(LPCN)
Patel Mahesh V.
— Director
Apr 2, 2026
Purchase
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuraxis, INC
(NRXS)
Henrichs Timothy Robert
— Chief Financial Officer
Apr 1, 2026
Purchase
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuraxis, INC
(NRXS)
Carrico Thomas Joeseph
— CRO, CCO, CPO
Apr 1, 2026
Purchase
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuraxis, INC
(NRXS)
Carrico Brian Allen
— Director
Apr 1, 2026
Purchase
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Altimmune, Inc.
(ALT)
Durso Jerome Benedict
— Director
Apr 1, 2026
Purchase
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Altimmune, Inc.
(ALT)
WEAVER GREGORY L
— Chief Financial Officer
Apr 1, 2026
Purchase
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Neal James R
— Director
Mar 31, 2026
Purchase
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
Lu Hongbo
— Director
Mar 31, 2026
Purchase
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Korro Bio, Inc.
(KRRO)
Lynx1 Capital Management LP
— 10% Owner
Mar 31, 2026
Purchase
Shares
520
Price
$10.60
Total Value
$5.51K
Shares Held After
1,538,296
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Guy Wendy
— Chief Administrative Officer
Mar 31, 2026
Purchase
Shares
1,854
Price
$2.54
Total Value
$4.70K
Shares Held After
3,110
% of Holdings
59.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Ng George K
— Director
Mar 31, 2026
Purchase
Shares
2,136
Price
$2.54
Total Value
$5.41K
Shares Held After
3,649
% of Holdings
58.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Lin Patrick
— Chief Business - Strategy Off
Mar 31, 2026
Purchase
Shares
1,603
Price
$2.54
Total Value
$4.06K
Shares Held After
3,356
% of Holdings
47.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Young David
— Director
Mar 31, 2026
Purchase
Shares
1,810
Price
$2.54
Total Value
$4.59K
Shares Held After
10,562
% of Holdings
17.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Pannu Geraldine
— Director
Mar 31, 2026
Purchase
Shares
2,072
Price
$2.54
Total Value
$5.25K
Shares Held After
2,188
% of Holdings
94.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
SKIBSTED RUSSELL
— Chief Financial Officer
Mar 31, 2026
Purchase
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Baluch Khoso
— Director
Mar 31, 2026
Purchase
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Bigora Sian
— Chief Development Officer
Mar 31, 2026
Purchase
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Connect Biopharma Holdings Ltd
(CNTB)
Huang James
— Director
Mar 31, 2026
Purchase
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
Fairmount Funds Management LLC
— Director
Mar 31, 2026
Purchase
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tonix Pharmaceuticals Holding Corp.
(TNXP)
LEDERMAN SETH
— Director
Mar 31, 2026
Purchase
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CURIS INC
(CRIS)
KAITIN KENNETH I
— Director
Mar 31, 2026
Purchase
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nasus Pharma Ltd
(NSRX)
Teleman Dan Benjamin
— Director
Mar 31, 2026
Purchase
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
MOULDER LEON O JR
— Director
Mar 31, 2026
Purchase
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
Lu Hongbo
— Director
Mar 31, 2026
Purchase
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Posner Brian S
— Director
Mar 30, 2026
Purchase
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
JENKINS GEORGE M
— Director
Mar 30, 2026
Purchase
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
MOULDER LEON O JR
— Director
Mar 30, 2026
Purchase
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rezolute, Inc.
(RZLT)
Evans Daron
— CFO
Mar 30, 2026
Purchase
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
RA CAPITAL MANAGEMENT, L.P.
— Director
Mar 30, 2026
Purchase
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Wave Life Sciences Ltd.
(WVE)
RA CAPITAL MANAGEMENT, L.P.
— Director
Mar 30, 2026
Purchase
Shares
971,091
Price
$6.50
Total Value
$6.31M
Shares Held After
26,975,505
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Showing 1–31 of 31 transactions (page 1 of 1)
Version: v26.3.33